Simone Hummler

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 490 citations · Full text

Antifibrotic Therapy, Advanced Lung Disease, Idiopathic Pulmonary Fibrosis +6

Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients

Johanna Nattenmüller, Raoul Wochner, Thomas Muley et al. · PLoS ONE · 2017 · 109 citations · Full text

Exercise in Patients with Non–Small Cell Lung Cancer

LEA KUEHR, Joachim Wiskemann, Ulrich Abel et al. · Medicine & Science in Sports & Exercise · 2013 · 85 citations

Clinical Correlates of Reduced Physical Activity in Idiopathic Pulmonary Fibrosis

Thomas Bahmer, Anne‐Marie Kirsten, Benjamin Waschki et al. · Respiration · 2016 · 79 citations

Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis

Thomas Bahmer, Anne‐Marie Kirsten, Benjamin Waschki et al. · BMC Pulmonary Medicine · 2017 · 76 citations · Full text